Novalis LifeSciences
Venture capitalPortsmouth · Seed–Late Stage · 9 people tracked
Find your way into Novalis LifeSciences
461 people in our graph share verified history with the Novalis LifeSciences team — schools, employers, funds. One of them is your warm intro.
Investment thesis
Novalis Advisory provides strategic advisory and investment banking services, including consulting on business organization and operations, financial and management matters, and executive and leadership development training and coaching.
Source: firm website, verified Aug 3, 2026.
Team · 9 people
from the firm's website & public directories
What they invest in
from 23 of 23 portfolio companiesBiotech ×14Medical Devices ×12Healthtech ×11AI & Machine Learning ×10Deep Tech ×9Digital Health ×4Hardware ×4AgTech ×3
HQs:United States×17Belgium×1
Investments · 23 tracked
founders shown can be your intro pathBy year:2025 · 22023 · 12022 · 52021 · 22020 · 42019 · 12017 · 116 dated
Quanterix develops technology for highly sensitive detection of protein biomarkers using non-invasive sample types, aimed at early disease detection and prevention.
BiotechDigital HealthHealthtechMedical DevicesLexington, US
David Walt(Director)inErnest Orticerio(Executive Officer)Ernest Oriticerio(Executive Officer)Masoud Toloue(Former Chief Executive Officer)in
BoardJohn Connolly(Director)inKeith Crandell(Director)
Board seatMarijn DekkersPaul Meister· per SEC Form D · $6.5M raise · filed Jul 2019
Co-investorsARCH Venture PartnersFoothill VenturesKhosla Ventures
Animol is a biopharmaceutical company developing a proprietary pipeline of novel veterinary small-molecule drugs for both companion and farm animals, targeting areas from anti-parasitics to chronic diseases.
AgTechAI & Machine LearningBiotechDeep TechHealthtechBoston, US
Andrew Calabrese(Scientific Co-Founder)inAndrew Calabrese, Ph.D.(Scientific Co-Founder)Douglas E. Hutchens(CSO)inLogan Andrews(Head of Program Management)inPhilip Austin(Managing Partner, Anterra Capital; co-founder of Animol)inAndrew Plant(Executive Officer, Director)in
Board seatMarijn Dekkers· per SEC Form D
Co-investorsAnterra CapitalDYDX Capital
Activ Surgical develops intraoperative surgical intelligence technology for surgeons, using AR, AI, machine learning, and sensing to display physiological structures and functions not visible to the naked eye.
AI & Machine LearningHealthtechMedical DevicesBoston, US
Peter Kim(Director)inMichael Ruehlman(Executive Officer)inTodd Usen(Executive Officer, Director)in
BoardEmily Casey(Director)Ashok Krishnamurthi(Director)inDavid Wells(Director)
Board seatPaul Meister· per SEC Form D · $15M raise · filed Jul 2020
Co-investorsReimagined VenturesAlumni VenturesArtis VenturesBasecamp FundCastor VenturesCota Capital+8 more
US agricultural biotech that discovered microbe-based crop protection products; its assets were sold to Certis Biologicals and Ginkgo Bioworks in 2024.
AgTechResearch Triangle Park, US
Scott Uknes(Manager)inEric Ward(Manager)Paul Schulze-Lefert(President)Michael Koziel(Vice President and Manager)
BoardThomas Dietz(Manager)Kristina Burow(Manager)in
Board seatMarijn Dekkers· per SEC Form D · $117.2M raise · filed Feb 2022
Co-investorsAliment CapitalBlue Horizon CorporationPontifax AgTechARCH Venture PartnersPolaris Partners
Flywheel provides a platform for organizing, managing, and sharing medical imaging data.
AI & Machine LearningData & InfrastructureHealthtechMedical DevicesMinneapolis, US
Brian Wandell(Co-founder)Gunnar Schaefer(Co-founder)inColby Moosman(Executive Officer)inMatthew D. Michela(Executive Officer, Director)inSarah Fazio(Executive Officer)Jim Olson(Executive Officer)in
Board seatMarijn DekkersPaul MeisterDevin Leake· per SEC Form D
Co-investors8VCBeringeaGreat North VenturesIntuitive VenturesiSelect FundLightbank+2 more
Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.
AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US
George Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)Terry Lo(Director)inSeth Benson(Executive Officer)inSimona Levi(Executive Officer)in
Board seatMarijn Dekkers· per SEC Form D · $37M raise · filed Apr 2021
Co-investorsARCH Venture PartnersM VenturesNorthpond VenturesIllumina Ventures
BlueWhale Bio develops manufacturing technologies for cell-based therapies, focusing on cell activation and expansion in early-stage processing to improve efficiency and reduce costs.
BiotechDeep TechMedical DevicesPhiladelphia, US
Peter Keller(Executive Officer, Director)in
BoardPaul Meister(Director)Elaine Heron(Director)Paula Cannon(Director)Beate Mueller-Tiemann(Director)
Co-investorsAscendo VenturesBaselayer CapitalCardanoGhaf Capital Partnersgumi IncPRIMAL CAPITAL+2 more
Enko discovers and develops novel crop protection products for farmers using a proprietary AI and machine learning discovery platform to combat pests and diseases.
AgTechAI & Machine LearningBiotech
Tom Meade(Chief Science Officer)
Co-investorsConnecticut InnovationsDYDX CapitalEndeavor8Germin8 VenturesAnterra CapitalEight Roads Ventures+1 more
Etherna is an RNA-LNP technology company that develops proprietary RNA chemistry and lipid nanoparticle delivery platforms for nucleic acid–based therapeutics, and partners with pharma and biotech organizations from early discovery through clinical development.
BiotechDeep TechMedical DevicesNiel, BE
Co-investorsFund+PMVBoehringer Ingelheim Venture FundEQT Life SciencesPWV
Flywheel provides a building operations platform for facility and property managers to manage maintenance teams, track preventative and ad hoc tasks, and analyze energy usage.
CleantechEnergyPropTechSaaSDallas, US
Steve Gossett, Jr.(CEO)Brian BezdekBrian Ratcliff
Co-investorsBraemar Energy Ventures8VCNVIDIA
WP Engine (Flywheel) provides enterprise-grade WordPress hosting infrastructure designed to support high-traffic websites with advanced caching, security, and network optimization.
Cloud ComputingDeveloper ToolsSaaSAustin, US
Jason Cohen(Founder)
Co-investorsNelnet8VCCratonHyde Park Venture PartnersNVIDIA
LevitasBio develops label-free cell isolation and analysis technology for life science researchers, enabling higher-quality cell sample preparation without introducing bias or gene expression modifications.
BiotechDeep TechHardwareMedical Devices
Dr. Gozde Durmus(Co-founder)Dr. Utkan Demirci(Co-founder)Dr. Lars Steinmetz(Co-founder)
Co-investorsDecheng Capital
Mercy BioAnalytics develops diagnostic tests for early cancer detection using advanced proteomics and genomics technologies.
BiotechDigital HealthHealthtechMedical DevicesNatick, US
Paul Blavin(Co-Founder & Vice Chairman)inStanley Lapidus(Director)inDawn Mattoon, PhD(Chief Executive Officer)Joseph Sedlak(Executive Officer, Director)
BoardPaul Meister(Director)Sonja Hoel Perkins(Director)in
Co-investorsHatteras Venture PartnersiSelect FundMindshift CapitalPortfoliaSozo VenturesThe Perkins Fund
Ori develops expandable-unit technology for multifamily real estate, enabling hotel-to-housing conversions and ground-up developments that increase unit density while maintaining livability.
Construction TechHardwareImpact & Social GoodPropTech
Co-investorsIngka InvestmentsPresidio VenturesThe E14 FundAmadeus Capital PartnersDelin VenturesKhosla Ventures+3 more
ORI provides an integrated business planning platform for supply chain professionals, combining demand planning, S&OP, S&OE, data analytics, and long-term planning in one tool.
AI & Machine LearningLogistics & Supply ChainSaaS
Brant Slade(Founder)in
Co-investorsKickstartAmadeus Capital PartnersDelin VenturesKhosla VenturesNorthpond VenturesOctopus Ventures+2 more
Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.
Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical Devices
Co-investorsAmadeus Capital PartnersKindred CapitalDelin VenturesNorthpond VenturesOctopus VenturesPuhua Capital
Orogen Therapeutics uses AI and machine learning to accelerate drug discovery, focusing on small molecule candidates for immuno-inflammatory diseases.
AI & Machine LearningBiotechDeep TechMedical Devices
Mark Pykett(Chief Executive Officer)
HealthtechCambridge, US
Rahul Dhanda(Executive Officer, Director)inJames Collins(Director)David Walt(Director)in
BoardIssi Rozen(Director)in
Co-investorsCatalio Capital Management, LPIllumina VenturesCatalio Capital ManagementGood VenturesGV (Google Ventures)Northpond Ventures
SkylineDx develops gene-based diagnostic tests that identify how patients will respond to treatment by analyzing genomic alterations in disease cells, serving oncology and dermatology care providers and patients.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSan Diego, US
Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices.
AI & Machine LearningBiotechDeep TechHardwareHealthtechSan Diego, US
Daniel G. Gibson(Executive Officer)inTodd R. Nelson(Executive Officer, Director)Eric Esser(Executive Officer)inWilliam F. Snider(Director)Andrea L. Jackson(Director)inChristine A. Tsingos(Director)
Co-investorsNorthpond Ventures
BiotechDigital HealthHealthtechMedical DevicesMiami, US
Matthew H. J. Kim(Executive Officer, Director)
BoardTimothy Barabe(Director)Eric Stone(Director)Jonathan T. Lord(Director)Jeffrey Goodman(Director)
AIRNA develops genetic medicines that use ADAR, a naturally occurring human protein, to precisely edit RNA and treat genetic diseases without permanently modifying DNA.
AI & Machine LearningBiotechDeep TechHealthtechStanford, US
Thorsten Stafforst(Chairman of the Board of Directors)inKris ElveruminTodd Bazemore(Chief Executive Officer)inJin (Billy) Li(Treasurer and Secretary)inPaul Vogel(Chief Executive Officer and President)in
BoardRodger Novak(Chair)in
Co-investors+ND CapitalARCH Venture PartnersForbionVenrockFast Track InitiativeNextech Invest+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Exits · 2
1 IPOs · 1 acquisitions · showing 1QuanterixNASDAQ: QTRX
Portfolio news
latest coverage across their companiesFlywheel · seekingalpha.com · Aug 19, 2026
Quanterix · investing.com · Aug 17, 2026
Telesis Bio · markets.businessinsider.com · Aug 14, 2026
Enko Chem · agropages.com · Aug 12, 2026
Activ Surgical · nasdaqprivatemarket.com · Apr 2, 2026
Vizgen · intelligence360.news · Feb 2, 2026
Flywheel · bizjournals.com · Jan 13, 2026
Frequently asked questions
- How many investments has Novalis LifeSciences made?
- Novalis LifeSciences has 23 tracked investments, 2 of which have exited, including 2 dated in the last 24 months.
- What stage does Novalis LifeSciences invest at?
- Novalis LifeSciences invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Novalis LifeSciences focus on?
- Novalis LifeSciences focuses on Biotech, Healthtech, Medical Devices.
- Where is Novalis LifeSciences located?
- Novalis LifeSciences is headquartered in Portsmouth, US.
- Does Novalis LifeSciences lead rounds?
- Novalis LifeSciences has led 6 of the 6 rounds where its role is on record.
- Who does Novalis LifeSciences co-invest with?
- Novalis LifeSciences most often shares deals with DYDX Capital, iSelect Fund, 8VC, among 24 tracked co-investors.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.